Laboratorios Farmaceúticos Rovi SA (LABFF)
67.17
0.00 (0.00%)
USD |
OTCM |
Nov 18, 16:00
Laboratorios Farmaceúticos Rovi Price : 67.17 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 18, 2026 | 67.17 | 67.17 | 67.17 | 67.17 | 0.000 |
| Nov 17, 2026 | 67.17 | 67.17 | 67.17 | 67.17 | 0.000 |
| Nov 16, 2026 | 67.17 | 67.17 | 67.17 | 67.17 | 0.000 |
| Nov 13, 2026 | 67.17 | 67.17 | 67.17 | 67.17 | 0.000 |
| Nov 12, 2026 | 67.17 | 67.17 | 67.17 | 67.17 | 0.000 |
| Nov 11, 2026 | 67.17 | 67.17 | 67.17 | 67.17 | 0.000 |
| Nov 10, 2026 | 67.17 | 67.17 | 67.17 | 67.17 | 0.000 |
| Nov 09, 2026 | 67.17 | 67.17 | 67.17 | 67.17 | 0.000 |
| Nov 06, 2026 | 67.17 | 67.17 | 67.17 | 67.17 | 0.000 |
| Nov 05, 2026 | 67.17 | 67.17 | 67.17 | 67.17 | 0.000 |
| Nov 04, 2026 | 67.17 | 67.17 | 67.17 | 67.17 | 0.000 |
| Nov 03, 2026 | 67.17 | 67.17 | 67.17 | 67.17 | 0.000 |
| Nov 02, 2026 | 67.17 | 67.17 | 67.17 | 67.17 | 0.000 |
| Oct 30, 2026 | 67.17 | 67.17 | 67.17 | 67.17 | 0.000 |
| Oct 29, 2026 | 67.17 | 67.17 | 67.17 | 67.17 | 0.000 |
| Oct 28, 2026 | 67.17 | 67.17 | 67.17 | 67.17 | 0.000 |
| Oct 27, 2026 | 67.17 | 67.17 | 67.17 | 67.17 | 0.000 |
| Oct 26, 2026 | 67.17 | 67.17 | 67.17 | 67.17 | 0.000 |
| Oct 23, 2026 | 67.17 | 67.17 | 67.17 | 67.17 | 0.000 |
| Oct 22, 2026 | 67.17 | 67.17 | 67.17 | 67.17 | 0.000 |
| Oct 21, 2026 | 67.17 | 67.17 | 67.17 | 67.17 | 0.000 |
| Oct 20, 2026 | 67.17 | 67.17 | 67.17 | 67.17 | 0.000 |
| Oct 19, 2026 | 67.17 | 67.17 | 67.17 | 67.17 | 0.000 |
| Oct 16, 2026 | 67.17 | 67.17 | 67.17 | 67.17 | 0.000 |
| Oct 15, 2026 | 67.17 | 67.17 | 67.17 | 67.17 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Almirall SA | 10.53 |
| AstraZeneca PLC | 175.22 |
| ANI Pharmaceuticals, Inc. | 69.60 |
| Corcept Therapeutics, Inc. | 64.46 |
| Veru, Inc. | 2.15 |
Price Related Metrics
| PE Ratio | 14.42 |
| PS Ratio | 3.573 |
| PEG Ratio | 0.193 |
| Price to Book Value | 3.878 |
| Price to Free Cash Flow | 25.89 |
| Earnings Yield | 6.93% |
| Market Cap | 3.435B |
| PEGY Ratio | 0.1889 |
| Operating PE Ratio | 17.71 |
| Normalized PE Ratio | 14.43 |